Ameritas Investment Partners, Inc. Amneal Pharmaceuticals, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.8 Billion
- Q1 2025
A detailed history of Ameritas Investment Partners, Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 15,590 shares of AMRX stock, worth $112,403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,590
Previous 15,590
-0.0%
Holding current value
$112,403
Previous $123,000
5.69%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AMRX
# of Institutions
244Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$114 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$88.9 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$81.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$77.4 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$54 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.09B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...